OPPM
CLVS
Opus Point Partners Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-82,430
| Closed | -$2.42M | – | 45 |
|
|
2018
Q3 | $2.42M | Buy |
82,430
+69,430
| +534% | +$2.04M | 5.78% | 3 |
|
|
2018
Q2 | $591K | Hold |
13,000
| – | – | 1.28% | 24 |
|
|
2018
Q1 | $686K | Sell |
13,000
-2,000
| -13% | -$106K | 1.35% | 24 |
|
|
2017
Q4 | $1.02M | Hold |
15,000
| – | – | 0.88% | 29 |
|
|
2017
Q3 | $1.24M | Hold |
15,000
| – | – | 1.11% | 29 |
|
|
2017
Q2 | $1.4M | Sell |
15,000
-15,000
| -50% | -$1.4M | 1.29% | 26 |
|
|
2017
Q1 | $1.91M | Hold |
30,000
| – | – | 1.42% | 27 |
|
|
2016
Q4 | $1.33M | Buy |
+30,000
| New | +$1.33M | 1.06% | 28 |
|
|
2016
Q2 | – | Sell |
-75,000
| Closed | -$1.44M | – | 52 |
|
|
2016
Q1 | $1.44M | Buy |
75,000
+25,000
| +50% | +$480K | 1.11% | 27 |
|
|
2015
Q4 | $1.75M | Sell |
50,000
-8,567
| -15% | -$300K | 1.16% | 26 |
|
|
2015
Q3 | $5.39M | Buy |
58,567
+6,167
| +12% | +$567K | 2.97% | 2 |
|
|
2015
Q2 | $4.61M | Sell |
52,400
-3,588
| -6% | -$315K | 3.65% | 6 |
|
|
2015
Q1 | $4.16M | Buy |
55,988
+28,988
| +107% | +$2.15M | 3.48% | 2 |
|
|
2014
Q4 | $1.51M | Buy |
+27,000
| New | +$1.51M | 1.5% | 26 |
|